UK Markets close in 3 hrs 10 mins
Personal finance:

Couples face 3 year stay with parents to save house deposit

“A rent-free stay in the family home is one way to quickly boost your savings"

Hexagon Purus AS: Notice of Annual General Meeting

  • Oops!
    Something went wrong.
    Please try again later.
Hexagon Purus Holding AS
·1-min read
  • Oops!
    Something went wrong.
    Please try again later.

The Annual General Meeting of Hexagon Purus AS will be held on 27 April 2021 at 12:30 CEST at the company's offices in Korsegata 4B, Aalesund, Norway.

Please find attached the notice of the Annual General Meeting with attendance/proxy forms and the Board of Directors' proposed resolutions for the Annual General Meeting.

Due to COVID-19, and to ensure accomplishment of the Annual General Meeting, shareholders are requested to participate in the Annual General Meeting by;

a) voting electronically in advance prior to the Annual General Meeting, or

b) participate by proxy, with or without voting instructions.

All documents related to the Annual General Meeting are available at www.hexagonpurus.com. Shareholders should note that additional information on proceedings of the meeting may be given and announced on the company's website and/or through a stock exchange announcement.

Contact:
Salman Alam, VP Corporate Development, Hexagon Purus AS
Telephone: +47 476 12 713 | salman.alam@hexagonpurus.com


About Hexagon Purus AS
Hexagon Purus, a Hexagon Composites company, is a world leading provider of hydrogen type 4 high-pressure cylinders, battery packs and vehicle systems integration for fuel cell electric and battery electric vehicles. Hexagon Purus enables zero emission solutions for light, medium and heavy-duty vehicles, buses, ground storage, distribution, maritime, rail and aerospace. Learn more at www.hexagonpurus.com and follow @HexagonPurus on LinkedIn and Twitter.


This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act


Attachment


Latest stories

  • Global Radiation Dermatitis Epidemiology Insight Report 2021-2030 Featuring Tempol (APC-400): Adamis Pharmaceuticals/Matrix Biomed and BMX-001: BioMimetix JV - ResearchAndMarkets.com

    The "Radiation Dermatitis - Epidemiology Insight - 2030" report has been added to ResearchAndMarkets.com's offering.

  • David Cameron's Austerity Agenda Was 'Very Successful', Says Jacob Rees-Mogg

    Commons leader praises under-fire former Conservative prime minister.

  • Poland starts J&J COVID-19 jabs, says benefits outweigh risks

    Poland started administering Johnson & Johnson COVID-19 shots on Thursday as benefits from the vaccine outweigh potential risks, government and drug office representatives said. U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson's vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot, dealing a fresh setback to efforts to tackle the pandemic. The head of the Office for Registration of Medicinal Products told the conference that benefits from the J&J vaccine outweigh potential risks.

  • Paroxysmal Nocturnal Hemoglobinuria Epidemiology Forecast to 2030: Two Roads Diverge - Treatment Choice in Coexisting Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria - ResearchAndMarkets.com

    The "Paroxysmal Nocturnal Hemoglobinuria - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

  • Worldwide Topical Pain Relief Industry to 2025 - by Therapeutic Class, Mode of Purchase and Region - ResearchAndMarkets.com

    The "Topical Pain Relief Market" report has been added to ResearchAndMarkets.com's offering.

  • PCT LTD Announces Fiscal 2020 Results

    PCT LTD (OTC Pink: "PCTL"), reported financial results for the fiscal year ended December 31, 2020.

  • Why Peter Lynch Would Love Lululemon Athletica

    The yoga-inspired retailer is the type of stock that would have gotten the legendary investor excited.

  • Jurassic Coast cliff collapses in biggest UK rockfall for 60 years

    Jurassic Coast cliff collapses in biggest UK rockfall for 60 years. People urged to stay away after thousands of tonnes falls to Dorset beach in massive chunks

  • 1 Question STORE Capital Needs to Answer

    Having proven it can survive a pandemic, STORE Capital now needs to shift gears and show what it can do in a different way.

  • Onychomycosis Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

    The onychomycosis market estimated to be valued at USD USD 2730. 72 million in 2020 and is expected to reach approximately USD 3781. 42 million in 2026, registering a CAGR of nearly 5. 75% during the forecast period.New York, April 15, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Onychomycosis Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" - https://www.reportlinker.com/p06062858/?utm_source=GNW Prior to the COVID-19 pandemic, clinical examination, dermoscopy, and mycological examination were recommended for all patients with suspected onychomycosis. However, with the spread of the COVID-19 pandemic, non-urgent in-person visits are being deferred, and telemedicine may be utilized to address some aspects of onychomycosis diagnosis and treatment. Telemedicine may be appropriately utilized to assess patients with suspected onychomycosis, but it is better optimized for patients with prior mycological confirmation.Hence, the market is expected to witness a short-term disruption due to the COVID-19 pandemic. However, the revenue growth rate is expected to recover during the forecast period, and the global onychomycosis market is estimated to digit growth trajectory.Onychomycosis, also known as tinea unguium, is a fungal infection of the fingernails or toenails that may involve any component of the nail unit, including the matrix, bed, or plate. This may cause pain, disfigurement, and discomfort and may produce serious issues, and results in reducing the quality of life. Onychomycosis is of different types such as superficial onychomycosis, distal and lateral subungual onychomycosis, proximal subungual onychomycosis, endonyx onychomycosis, and total dystrophic onychomycosis. Onychomycosis accounts for one-third of fungal skin infections because only about one-half of nail dystrophies are caused by fungus.Increasing the geriatric population, rising prevalence of onychomycosis, and diabetic population worldwide and growing awareness about the potential threats of onychomycosis are the key driving factors in the onychomycosis treatment market.In addition, according to the United Nations Department of Economics and Social’s 2019 report, by 2050, 1 in 6 people around the world will be over the age of 65 (16%), up from 1 in 11 people in 2019 (9%). By 2050, 1 in 4 persons living in Europe and North America could be aged 65 years or above. The number of persons aged 80 years and above is projected to triple, from 143 million in 2019 to approximately 426 million in 2050.?Key Market TrendsThe Drugs Segment is Expected to Hold a Major Market Share in the Onychomycosis Treatment MarketSome of the drugs available for the treatment of onychomycosis are terbinafine, ciclopirox, Jublia, fluconazole, Penlac, Ciclodan, ketoconazole, Sporanox, itraconazole, Kerydin, efinaconazole, griseofulvin, and so on. For onychomycosis treatment, drugs remain the first-line choice of treatment with major market share owing to a consistently high success rate.As per Elewski and Charif onychomycosis report, states that approximately 40% of the elderly population have onychomycosis. Moreover, a reduction in nail growth rate ranges from about 40% to 60% in persons more than 65 years of age. Furthermore, onychomycosis affects approximately 2% to 26% of different populations globally. Moreover, less than 30% of infected individuals with onychomycosis seek medical advice or treatment in developed countries.The drugs segment holds a significant market share in the onychomycosis treatment market and is anticipated to show a similar trend over the forecast period due to the highly effective and easy availability of the products. In February 2019, Moberg Pharma entered into a license agreement granting the Consumer Health division of Bayer exclusive European rights to MOB-015, a new topical treatment of onychomycosis based on Moberg’s patented proprietary formulation of terbinafine. Bayer will be marketing, distributing, and selling MOB-015 in Europe upon completion of Phase III clinical development and registration.Morover, with the COVID 19 pandemic, distribution of the drugs has been disrupeted all over the world due to the supply chain disruptions and expected to have impact in 2020, however, in late 2020 , 2021 and further years, market is for onychomycosis expected to recover and expected to show positive growth over the period.North America is Expected to Hold a Significant Share in the Market in the Forecast PeriodNorth America is expected to hold a major market share in the global onychomycosis treatment market due to high drug costs, rising geriatric population, increasing prevalence of onychomycosis, and diabetic patient population in this region. According to the United States Census Bureau 2019 Population Estimates, the 65-and-older population grew by 3.2% (1,688,924) from 2018 to 2019 to reach over 54 million. In people aged 65 years and older, the prevalence of diabetes was found to be 26.8% (total diabetes prevalence).The reasons for the age-related increase in onychomycosis include a variety of factors, like repeated nail trauma, poor peripheral circulation, diabetes, suboptimal immune function, longer exposure to pathogenic fungi, inactivity, or the inability to cut the toenails or maintain good foot care. Various strategies, such as research and development, mergers and acquisitions, and product launches, are being adopted by domestic companies to strengthen their market position.In October 2020, United States-headquartered Pfizer Inc. announced that it had begun clinical studies concerning onychomycosis. The first one involved a study in determining whether the AN2690 topical solution is an effective treatment for onychomycosis of the toenail. The second one was an open-label study to evaluate the safety and pharmacokinetics of tavaborole 5% topical solution to treat distal subungual onychomycosis of the toenail in both children and adolescents.On the other hand COVID 19 pandemic has resulted decreased diagnosis and impacted the sales revenue of drugs and other treatment methods for onychomycosis as there is focus of hospitals and primary care centers for COVID 19 patients .Competitive LandscapeThe onychomycosis treatment market is fragmented competitive and consists of several major players. Companies are focusing on developments, collaborations, new product launches and to strengthen their market position. For instance, In April 2020, the United States Food and Drug Administration expanded the approval of Jublia manufactured by Bausch Health. Jublia is a topical solution use in the treatment of onychomycosis of the toenail(s) in patients aged six years and above.Some of the players which are currently dominating the market are Bausch Health Companies Inc. (Valeant Pharmaceuticals Inc.), Galderma SA, Novartis AG, Pfizer Inc., Moberg Pharma AB, Johnson & Johnson, Bayer AG, Dr. Reddy’s Laboratories Ltd, Cipla Ltd, Medimetriks Pharmaceuticals Inc., and Lumenis Ltd.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRead the full report: https://www.reportlinker.com/p06062858/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • French MPs approve controversial security bill restricting police images

    France’s parliament passed a security bill Thursday to extend police powers despite criticism from civil rights activists who fear it threatens efforts to denounce police abuse. The bill was approved by 75 votes for and 33 against at the National Assembly, where French President Emmanuel Macron’s party, which proposed the measure, has a large majority. The Senate has already adopted the bill. In an effort to quell criticism, lawmakers have redrafted the most controversial article of the text. It now says helping to identify on-duty police officers “with the obvious intent of harming'' will be punished by up to 5 years in prison and a 75,000 euro-fine ($89,800). Tens of thousands of protesters marched in Paris in November to denounced the initial provision that was making it illegal to publish images of police officers with intent to cause them harm.Opponents say the new draft still remains vague and subject to interpretation by police officers. They also fear it will intimidate people trying to fight police abuse and discrimination by taking and publishing pictures and videos. Macron’s government said the law was needed to better protect police amid threats and attacks by a violent fringe and increasing harassment on social media. Interior Minister Gerald Darmanin on Thursday praised the “compromise” that lawmakers found on the text. The bill also gives more autonomy to local police and extends the use of surveillance drones, amid other measures.The French branch of Amnesty International warned on Twitter about the “dangers” the bill posed to civil liberties and denounced its “generalized surveillance practices.”The text has “vague provisions that could allow abusive and unfair legal proceedings," the rights group said. (AP)

  • Risk of rare blood clots far higher for Covid-19 than for vaccines – study

    Oxford scientists said their research should be taken into account when considering the balances between the risks and benefits of vaccination.

  • U.S.'s Blinken flies to Afghanistan in show of support after Biden's pull-out announcement

    U.S. Secretary of State Antony Blinken flew to Kabul on Thursday to show support for the Afghan government a day after U.S. President Joe Biden announced that he was pulling U.S. forces out after nearly 20 years of war. Biden's decision precipitated a decision by NATO allies to withdraw their troops as well, even as the government of Afghan President Ashraf Ghani remains embroiled in fierce fighting with Taliban insurgents and a U.S.-backed peace process shrouded in uncertainty. Blinken went to meet with Ghani at the presidential palace after first greeting U.S. soldiers at the heavily fortified American embassy.

  • Acorio Adds Vice President of Consulting Services and Names New ServiceNow Practice Leads

    Today Acorio announced several key changes and promotions in their client delivery organization to better serve customers at scale.

  • Intellicheck Announces Appointments of Senior Vice President Sales and Vice President Marketing

    Intellicheck has announced the appointment of Bruce Ackerman as Senior Vice President of Sales and David Andrews as Vice President of Marketing.

  • Worldwide Silicon on Insulator Industry to 2027 - Increasing use of SoI Technology in IoT Devices and Applications Presents Opportunities

    Dublin, April 15, 2021 (GLOBE NEWSWIRE) -- The "Silicon on Insulator Market by Wafer Size, Wafer Type, Technology, Product and Application: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global silicon on insulator market size was $1.11 billion in 2019, and is projected to reach $3.18 billion by 2027, growing at a CAGR of 14.1% from 2020 to 2027. Silicon on insulator technology states the usage of layered silicon-insulator-silicon substrate in position of traditional silicon in semiconductor manufacturing work. This technology is compatible with presently used fabrication process in the industry without retooling or extra equipment of existing factory. There are several benefits of silicon on insulator technology such as high performance, power saving, reduced leakage, absence of latchup, compatibility, and ease in scaling.Silicon on insulator (SoI) is an integral part of consumer electronics products such as tablets, smartphones, wearable devices, electric cars, and others. Thus, demand for SoI is increasing rapidly in consumer electronics. Also, the need for reducing power consumption in a variety of mobile and portable devices has fueled the demand for SOI devices in the consumer electronic industry.Further, the SoI wafers offer the reliability, speed, and hardness beyond traditional technologies, which increases the overall operational performance at low voltage, which is further expected to contribute to the silicon on insulators market growth. Silicon on insulator catches lot of attention in the design of high-performance circuits. In recent times, chipmakers giants such as Advanced Micro Devices, IBM and Intel Corporation have taken surging interest in the commercialization of SOI technology.The minor restructuring in the current chip fabrication methods has enabled several manufactures to shift from the bulk silicon technology to the SOI-based devices. However, the self-heating effects in SOI-based devices act as restraints to the growth of the silicon on insulator market. Moreover, the market players faced challenges in procuring the raw material and delivering the finished goods with the interrupted supply chain.The silicon on insulator market is segmented on the basis of wafer size, wafer type, technology, product, application, and region. The wafer size segment includes 200 mm and 300 mm wafers. Based on wafer type, the market is divided into RF-SOI, FD_SOI, PD-SOI, and others. By Technology, the market is segmented into BESOI, SiMOX, Smart Cut, ELTRAN, and SoS. By product, the silicon on insulator market bifurcated into optical communication, image sensing, MEMS, power, and RF FEM. By application, the market is segmented into datacom & telecom, automotive, consumer electronics, industrial, photonics, and others.By region, the silicon on insulator market trends are analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is studied across the U.S., Mexico, and Canada. Europe is analyzed across the UK, Germany, France, Russia, and the rest of Europe. The countries covered under Asia-Pacific are China, Taiwan, Japan, South Korea, and rest of Asia-Pacific, while LAMEA includes Latin America and Middle East & Africa. In addition, the report covers country-wise cross-sectional analysis of the products and industry vertical segments.The key players profiled in the report include GlobalWafers, NXP Semiconductors, SUMCO CORPORATION, Shin-Etsu Chemical Co., Ltd., MagnaChip Semiconductor Corp, STMicroelectronics, Soitec SA, Simgui, Tower Semiconductor Ltd. (ToweJazz), and Murata Manufacturing Co. Ltd. These key players have adopted various strategies, such as product portfolio expansion, mergers & acquisitions, agreements, geographical expansion, and collaborations, to enhance their position in the silicon on insulator industry. Key Topics Covered: Chapter 1: Introduction1.1. Report description1.2. Key benefits for Stakeholders1.3. Key Market Segments1.4. Research methodology1.4.1. Primary research1.4.2. Secondary research1.4.3. Analyst tools and modelsCHAPTER 2: Executive summary2.1. CXO perspectiveCHAPTER 3: MARKET OVERVIEW3.1. Market definition and scope3.2. Key findings3.2.1. Top impacting factors3.2.2. Top investment pockets3.3. Porter's five forces analysis3.4. Market dynamics3.4.1. Drivers3.4.1.1. Surge in usage of SoI wafers in consumer electronics3.4.1.2. Enhances operational performance with low operating voltage3.4.1.3. Increasing investments by wafer manufacturers and foundry players in emerging economies3.4.2. Restraint3.4.2.1. Self-heating effects in SoI based devices3.4.3. Opportunities3.4.3.1. Increasing use of SoI technology in IoT devices and applications3.4.3.2. Implementing automation solutions across the retail industry to avoid human intervention3.4.4. Challenges3.4.4.1. Volatility in cost of raw materials3.5. COVID-19 impact analysis3.5.1. Impact on market size3.5.2. End user trends, preferences, and budget impact3.5.3. Parent industry impactCHAPTER 4: silicon on insulator Market, By wafer size4.1. Overview4.2.200 mm4.2.1. Key market trends, growth factors, and opportunities4.2.2. Market size and forecast, by region4.2.3. Market analysis, by country4.3.300 mm4.3.1. Key market trends, growth factors, and opportunities4.3.2. Market size and forecast, by region4.3.3. Market analysis, by countryCHAPTER 5: silicon on insulator Market, BY wafer type5.1. Overview5.2. RF-SOI5.2.1. Key market trends, growth factors, and opportunities5.2.2. Market size and forecast, by region5.2.3. Market analysis, by country5.3. FD-SOI5.3.1. Key market trends, growth factors, and opportunities5.3.2. Market size and forecast, by region5.3.3. Market analysis, by country5.4. PD-SOI5.4.1. Key market trends, growth factors, and opportunities5.4.2. Market size and forecast, by region5.4.3. Market analysis, by country5.5. Others5.5.1. Key market trends, growth factors, and opportunities5.5.2. Market size and forecast, by region5.5.3. Market analysis, by countryCHAPTER 6: silicon on insulator Market, BY Technology6.1. Overview6.2. BESOI6.2.1. Key market trends, growth factors, and opportunities6.2.2. Market size and forecast, by region6.2.3. Market analysis, by country6.3. SiMOX6.3.1. Key market trends, growth factors, and opportunities6.3.2. Market size and forecast, by region6.3.3. Market analysis, by country6.4. Smart Cut6.4.1. Key market trends, growth factors, and opportunities6.4.2. Market size and forecast, by region6.4.3. Market analysis, by country6.5. ELTRAN6.5.1. Key market trends, growth factors, and opportunities6.5.2. Market size and forecast, by region6.5.3. Market analysis, by country6.6. SoS6.6.1. Key market trends, growth factors, and opportunities6.6.2. Market size and forecast, by region6.6.3. Market analysis, by countryCHAPTER 7: silicon on insulator Market, BY product7.1. Overview7.2. RF FEM7.2.1. Key market trends, growth factors, and opportunities7.2.2. Market size and forecast, by region7.2.3. Market analysis, by country7.3. MEMS7.3.1. Key market trends, growth factors, and opportunities7.3.2. Market size and forecast, by region7.3.3. Market analysis, by country7.4. Power7.4.1. Key market trends, growth factors, and opportunities7.4.2. Market size and forecast, by region7.4.3. Market analysis, by country7.5. Optical Communication7.5.1. Key market trends, growth factors, and opportunities7.5.2. Market size and forecast, by region7.5.3. Market analysis, by country7.6. Image Sensing7.6.1. Key market trends, growth factors, and opportunities7.6.2. Market size and forecast, by region7.6.3. Market analysis, by countryCHAPTER 8: silicon on insulator Market, BY Application8.1. Overview8.2. Consumer electronics8.2.1. Key market trends, growth factors, and opportunities8.2.2. Market size and forecast, by region8.2.3. Market analysis, by country8.3. Automotive8.3.1. Key market trends, growth factors, and opportunities8.3.2. Market size and forecast, by region8.3.3. Market analysis, by country8.4. Datacom & Telecom8.4.1. Key market trends, growth factors, and opportunities8.4.2. Market size and forecast, by region8.4.3. Market analysis, by country8.5. Industrial8.5.1. Key market trends, growth factors, and opportunities8.5.2. Market size and forecast, by region8.5.3. Market analysis, by country8.6. Photonics8.6.1. Key market trends, growth factors, and opportunities8.6.2. Market size and forecast, by region8.6.3. Market analysis, by country8.7. Others8.7.1. Key market trends, growth factors, and opportunities8.7.2. Market size and forecast, by region8.7.3. Market analysis, by countryCHAPTER 9: silicon on insulator Market, BY Region9.1. Overview9.2. North America9.3. Europe9.4. Asia-Pacific9.5. LAMEACHAPTER 10: COMPETITIVE LANDSCAPE10.1. Introduction10.1.1. Market player positioning, 201910.2. Competitive dashboard10.3. Competitive heatmap10.4. Key developments10.4.1. New product launches10.4.2. Collaborations10.4.3. Other DevelopmentsCHAPTER 11: COMPANY PROFILES11.1. TOWER SEMicONDUCTOR LTD.11.1.1. Company overview11.1.2. Key Executive11.1.3. Company snapshot11.1.4. Operating business segments11.1.5. Product portfolio11.1.6. R&D Expenditure11.1.7. Business performance11.1.8. Key strategic moves and developments11.2. GLOBAL WAFERS CO., LTD.11.2.1. Company overview11.2.2. Key Executive11.2.3. Company snapshot11.2.4. Operating business segments11.2.5. Product portfolio11.2.6. R&D Expenditure11.2.7. Business performance11.3. MagnaChip Semiconductor Corporation11.3.1. Company overview11.3.2. Key Executive11.3.3. Company snapshot11.3.4. Operating business segments11.3.5. Product portfolio11.3.6. R&D Expenditure11.3.7. Business performance11.3.8. Key strategic moves and developments11.4. MURATA MANUFACTURING COMPANY, LTD.11.4.1. Company overview11.4.2. Key Executive11.4.3. Company snapshot11.4.4. Operating business segments11.4.5. Product portfolio11.4.6. R&D Expenditure11.4.7. Business performance11.4.8. Key strategic moves and developments11.5. NXP Semiconductor11.5.1. Company overview11.5.2. Key Executives11.5.3. Company snapshot11.5.4. Product portfolio11.5.5. R&D Expenditure11.5.6. Business performance11.5.7. Key strategic moves and developments11.6. SHIN-ETSU CHEMicAL CO., LTD11.6.1. Company overview11.6.2. Key Executives11.6.3. Company snapshot11.6.4. Operating business segments11.6.5. Product portfolio11.6.6. R&D Expenditure11.6.7. Business performance11.6.8. Key strategic moves and developments11.7. Shanghai Simgui Technology Co., Ltd.11.7.1. Company overview11.7.2. Key Executive11.7.3. Company snapshot11.7.4. Product portfolio11.8. Soitec11.8.1. Company overview11.8.2. Key Executive11.8.3. Company snapshot11.8.4. Operating business segments11.8.5. Product portfolio11.8.6. R&D Expenditure11.8.7. Business performance11.8.8. Key strategic moves and developments11.9. STMicroelectronics N. V.11.9.1. Company overview11.9.2. Key Executives11.9.3. Company snapshot11.9.4. Operating business segments11.9.5. Product portfolio11.9.6. R&D Expenditure11.9.7. Business performance11.9.8. Key strategic moves and developments11.10. SUMCO CORPORATION11.10.1. Company overview11.10.2. Key Executives11.10.3. Company snapshot11.10.4. Operating business segments11.10.5. Product portfolio11.10.6. R&D Expenditure11.10.7. Business performanceFor more information about this report visit https://www.researchandmarkets.com/r/8z071v CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Line Of Duty Star Gregory Piper Hints Ryan Pilkington Could Kill Again: 'Anything Is On The Table'

    The OCG member, who is masquerading as a copper, has already killed PC Lisa Patel – who could be next?

  • Paul O’Connell sees Owen Farrell as outstanding candidate to lead Lions

    O’Connell was at the helm for the Lions’ last series against the Springboks in 2009.

  • Gucci family criticises ‘horrible, ugly’ casting of biopic film

    Gucci family criticises ‘horrible, ugly’ casting of biopic film. Members of fashion dynasty hit out at roles played by Al Pacino and Jared Leto in House of Gucci

  • Lidl has launched a stylish sail shaped garden parasol featuring LED lights for the evening

    Perfect for sunny days and Spring evenings.